Biohaven Pharmaceutical News

Company Name Stock Ticker Symbol Market Type
Biohaven Pharmaceutical Holding Company Ltd BHVN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.24 0.16% 148.00 16:34:46
Open Price Low Price High Price Close Price Prev Close
147.70 147.69 148.03 148.00 147.76
more quote information »

Recent News

Date Time Source Heading
8/05/202216:14EDGARQuarterly Report (10-q)
8/05/202207:00PRNUSBiohaven Reports Second Quarter 2022 Financial Results and..
7/28/202207:30PRNUSAmerican Migraine Foundation Survey Shows Nearly All People..
7/07/202207:30PRNUSBiohaven Enrolls First Patient in Phase 3 Trial of..
7/06/202213:00BWGlobal Coalition for Adaptive Research, Biohaven, and Vigeo..
7/01/202217:22EDGARProxy Statement - Merger or Acquisition (preliminary)..
6/28/202217:29EDGARCurrent Report Filing (8-k)
6/13/202207:30PRNUSBiohaven Presents New Migraine Data at 64th Annual..
6/10/202208:42EDGARSchedule 13g
(sc 13g/a)
6/09/202207:30PRNUSBiohaven Underscores Depth of Migraine Portfolio with Data..
5/23/202210:45TRMNBiohaven Pharmaceutical Holding Co (BHVN) Receives a Buy..
5/23/202207:30PRNUSUS FDA Accepts for Review Biohaven's New Drug Application..
5/23/202207:15PRNUSBiohaven Provides Update on Phase 3 Clinical Trial..
5/16/202206:45EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/11/202216:19EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/11/202209:05TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
5/10/202218:36EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/10/202218:33EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/10/202218:27EDGARQuarterly Report (10-q)
5/10/202218:26EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/10/202210:09DJNBiohaven Shares Soar on Takeover by Pfizer
5/10/202207:44EDGARCurrent Report Filing (8-k)
5/10/202207:28DJNPfizer to Buy Rest of Biohaven for $11.6 Billion
5/10/202207:16EDGARCurrent Report Filing (8-k)
5/10/202206:50PRNUSBiohaven Reports First Quarter 2022 Financial Results and..
5/10/202206:45BWPfizer to Acquire Biohaven Pharmaceuticals
5/09/202207:30PRNUSBiohaven to Discuss First Quarter 2022 Financial Results and..
5/04/202208:42TRMNBiohaven Pharmaceutical Holding Co (BHVN) Receives a Buy..
5/02/202220:36TRMNBiohaven Pharmaceutical Holding Co (BHVN) Gets a Buy Rating..
4/29/202217:49EDGARCurrent Report Filing (8-k)
4/27/202206:45BWPfizer and Biohaven’s VYDURA® (Rimegepant) Granted First..
4/15/202214:31EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/15/202214:26EDGARCurrent Report Filing (8-k)
4/14/202216:30PRNUSBiohaven Real-World Study Highlights Increased Healthcare..
4/14/202207:30PRNUSBiohaven Announces Expanded Patient Access to Nurtec® ODT..
4/07/202207:30PRNUSBiohaven Presentation at AAN Showed Decreased Opioid Use in..
4/06/202207:30PRNUSBiohaven Expands Commitment to Supporting Veterans and..
4/05/202216:40EDGARCurrent Report Filing (8-k)
4/03/202218:20TRMNBiohaven Pharmaceutical Holding Co (BHVN) Receives a Buy..
4/01/202207:30PRNUSNurtec (rimegepant) Lactation Clinical Study Published in..
3/31/202207:30PRNUSBiohaven Data at 2022 American Academy of Neurology (AAN)..
3/11/202216:47EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
2/25/202218:37EDGARAnnual Report (10-k)
2/25/202216:19EDGARCurrent Report Filing (8-k)
2/25/202210:01SEEKAerie, Schrodinger top healthcare gainers; while Baudax Bio,..
2/25/202208:40SEEKPfizer, Biohaven's rimegepant gets EMA panel nod for..
2/25/202207:49SEEKBiohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by..
2/25/202207:42DJNBiohaven, Pfizer Gets CHMP Backing for Migraine Drug
2/25/202207:39SEEKBiohaven in licensing pact with Bristol Myers; to acquire..

Your Recent History
Biohaven P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now